Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases(2022)
Abstract
Lay Summary We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.
MoreTranslated text
Key words
Vaccines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined